Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insmed (INSM) Gains from Sales and Divestitures (2016 - 2017)

Insmed's Gains from Sales and Divestitures history spans 6 years, with the latest figure at $89194.0 for Q2 2017.

  • Quarterly Gains from Sales and Divestitures rose 104.79% to $89194.0 in Q2 2017 from the year-ago period, while the trailing twelve-month figure was $89194.0 through Jun 2017, up 104.79% year-over-year, with the annual reading at $43554.0 for FY2016, 62.98% up from the prior year.
  • Gains from Sales and Divestitures came in at $89194.0 for Q2 2017, up from $43554.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $177316.0 in Q4 2013 to a low of $17568.0 in Q1 2015.
  • The 5-year median for Gains from Sales and Divestitures is $68803.0 (2013), against an average of $74468.2.
  • Year-over-year, Gains from Sales and Divestitures tumbled 80.89% in 2015 and then surged 147.92% in 2016.
  • Insmed's Gains from Sales and Divestitures stood at $177316.0 in 2013, then crashed by 47.75% to $92641.0 in 2014, then crashed by 71.15% to $26724.0 in 2015, then surged by 62.98% to $43554.0 in 2016, then skyrocketed by 104.79% to $89194.0 in 2017.
  • Per Business Quant, the three most recent readings for INSM's Gains from Sales and Divestitures are $89194.0 (Q2 2017), $43554.0 (Q4 2016), and $43554.0 (Q3 2016).